Quantum BioPharma (QNTM) will be back in the Ontario Superior Court of Justice on January 24, 2025. Quantum BioPharma is seeking a Court Order ...

Member of the Board of Managing Directors and Head of Human Pharma at Boehringer Ingelheim. "In the near future more can be expected. Our gratitude goes to the patients and clinical investigators ...

Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will showcase new product innovations for the industry-leading Visage 7 Enterprise Imaging ...

ALPHARETTA, Ga., Jan. 13, 2025 /PRNewswire/ -- Medicus IT, a leading Healthcare Solutions Provider (HSP) today announced the appointment of John Carter as its Chief Operations Officer (COO). Carter ...

MELBOURNE, Australia and INDIANAPOLIS, Jan. 12, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has entered into an asset purchase ...

Pro Medicus has a decade-long net profit CAGR of ~38% but trades at an extraordinary P/E of 335, reflecting its high growth and elevated valuation risks FY24 results showcased strong earnings growth ...

Medicus Pharma Ltd is listed on the CBOE trading with ticker code MDCXW.US. It has a market capitalisation of -, with approximately 0.00 shares in issue. Over the last year, Medicus Pharma Ltd ...

sharewise wants to provide you with the best news and tools for Medicus Pharma Ltd., so we directly link to the best financial data sources.

However, following representations from various industry associations representing pharma MSMEs seeking extension of this deadline, a draft notification has been issued by the Department of Health ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...